Second neoplasms in patients with chronic lymphocytic leukemia

Current Treatment Options in Oncology

Volumn 5, Issue 3, 2004, Pages 215-223

  Wiernik, Peter H ^a  

^a Our Lady of Mercy Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CLADRIBINE; DIETHYLSTILBESTROL; FLUDARABINE; FLUOROURACIL; IMIQUIMOD; NUCLEOSIDE DERIVATIVE; PREDNISONE; SULINDAC;

ACUTE GRANULOCYTIC LEUKEMIA; ANAPLASTIC CARCINOMA; BOWEN DISEASE; BREAST CANCER; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COLON CANCER; FREQUENCY ANALYSIS; HUMAN; KIDNEY CARCINOMA; LARGE CELL CARCINOMA; LEUKEMIA REMISSION; LUNG CANCER; MYELODYSPLASIA; PHOTODYNAMIC THERAPY; PROSTATE CANCER; REVIEW; RICHTER SYNDROME; SECOND CANCER; SKIN CARCINOMA; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; VIRUS PATHOGENESIS; LUNG TUMOR; NONHODGKIN LYMPHOMA; PATHOLOGY; SKIN TUMOR;

HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; NEOPLASMS, SECOND PRIMARY; SKIN NEOPLASMS;

EID: 4444368179     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-004-0013-7     Document Type: Review

References (82)

1. Wiernik PH, Hu X, Ratech H, et al.: Non-Hodgkin's lymphoma in women with breast cancer. Cancer J 2000, 6: 336-342.
2. Sakai T, Ogura Y, Narita J, et al.: Simultaneous early adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection. Gastric Cancer 2003, 6: 191-196.
3. Dincol D, Arican A, Ensari A, et al.: Concurrent occurrence of three neoplasms including non-Hodgkin's lymphoma, renal cell carcinoma and leiomyoma in the same kidney. Med Oncol 1999, 16: 134-138.
4. Padmanabhan V, Trainer TD: Synchronous adenocarcinoma and mantle cell lymphoma of the colon. Arch Pathol Lab Med 2003, 127: E64-E66.
5. McKenna DB, Stockton D, Brewster DH, Doherty VR: Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 2003, 88: 74-78.
6. Etkind P, Du J, Khan A, et al.: Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res 2000, 6: 1273-1278.
7. Rohwedder A, Philips B, Malfetano J, et al.: Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature. Am J Dermatopathol 2002, 24: 230-240.
8. Kamel D, Turpeenniemi-Hujanen T, Vahakangas K, et al.: Proliferating cell nuclear antigen but not p53 or human papilloma virus DNA correlates with advanced clinical stage in renal cell carcinoma. Histopathology 1994, 25: 339-347.
9. Manusow D, Weinerman BH: Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 1975, 232: 267-269.
10. Greene MH, Hoover RN, Fraumeni JF Jr: Subsequent cancer in patients with chronic lymphocytic leukemia: a possible immunologic mechanism. J Natl Cancer Inst 1978, 61: 337-340.
11. Santoro A, Rilke F, Franchi F, Monfardini S: Primary malignant neoplasms associated with chronic lymphocytic leukemia. Tumori 1980, 66: 431-437.
12. Harvey EB, Brinton LA: Second cancer following cancer of the breast in Connecticut 1935-82. Natl Cancer Inst Monogr 1985, 68: 99-112.
13. Davis JW, Weiss NS, Armstrong BK: Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1987, 78: 91-94.
14. Bertoldero G, Scribano G, Podda L, et al.: Occurrence of second neoplasms in chronic lymphocytic leukemia: experience at Padua Hospital between 1979 and 1991. Ann Hematol 1994, 69: 195-198.
15. Suzuki K, Maekawa I, Mikuni C, et al.: Prognosis in 75 cases of chronic lymphocytic leukemia and second malignancies. Rinsho Ketsueki 1997, 38: 740-744.
16. Hisada M, Biggar RJ, Greene MH, et al.: Solid tumors after chronic lymphocytic leukemia. Blood 2001, 98: 1979-1981.
17. Duggan DB, Petroni GR, Johnson JL, et al.: Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol 2003, 21: 607-614.
18. Smith RE: Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience. Clin Breast Cancer 2003, 4: 273-279.
19. Keating MJ, O'Brien S, Lerner S, et al.: Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 1998, 92: 1165-1171.
20. Cheson BD, Vena DA, Barrett J, Freidlin B: Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol 1999, 17: 2454-2460.
21. Cohen Y, Da'as N, Libster D, et al.: Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication? Eur J Haematol 2002, 68: 80-83.
22. Morrison VA, Rai KR, Peterson BL, et al.: Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, Cancer and Leukemia Group B 9011. J Clin Oncol 2002, 20: 3878-3884.
23. Lai R, Arber DA, Brynes RK, et al.: Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome: a report of five cases and review of the literature. Am J Clin Pathol 1999, 111: 373-378.
24. Barresi GM, Albitar M, O'Brien SM: Acute myeloid leukemia, inversion 16, occurring in a patient with chronic lymphocytic leukemia. Leuk Lymphoma 2000, 38: 621-625.
25. Miller MK, Strauchen JA, Nichols KT, Phelps RG: Concurrent chronic lymphocytic leukemia cutis and acute myelogenous leukemia cutis in a patient with untreated CLL. Am J Dermatopathol 2001, 23: 334-340.
26. Raz I, Polliack A: Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma: simultaneous presentation in three patients. Cancer 1984, 53: 83-85.
27. Ornellas De Souza MH, de Souza Fernandez T, Diamond HR, et al.: Cytogenetic and immunophenotypic evidence of independent clonal origin of concomitant chronic lymphocytic leukaemia and acute myeloid leukaemia. Eur J Haematol 2001, 66: 281-283.
28. Salim R, Wang L, Lin K, Clark RE: Chronic lymphocytic leukaemia developing in the course of chronic myeloid leukemia. Leuk Lymphoma 2002, 43: 2225-2227.
29. Mansat-De Mas V, Rigal-Huguet F, Cassar G, et al.: Chronic myeloid leukemia associated with B-cell chronic lymphocytic leukemia: evidence of two separate clones as shown by combined cell-sorting and fluorescence in situ hybridization. Leuk Lymphoma 2003, 44: 867-869.
30. Yahata N, Iwase O, Tauchi T, et al.: Chronic lymphocytic leukemia complicated by plasmacytoma originating from different clones. Leuk Lymphoma 2000, 39: 203-207.
31. Patriarca F, Gaidano G, Capello D, et al.: Occurrence of multiple myeloma after fludarabine treatment of chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation. Haematologica 2000, 85: 982-985.
32. Chang H, Wechalekar A, Li L, Reece D: Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin. Cancer Genet Cytogenet 2004, 148: 44-48.
33. Barton JC: Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia. Am J Hematol 2003, 74: 205-207.
34. Makower D, Venkatraj U, Dutcher JP, Wiernik PH: Occurrence of myeloma in a chronic lymphocytic leukemia patient after response to differentiation therapy with interleukin-4. Leuk Lymphoma 1996, 23: 617-619.
35. Larsen CR, Hansen PB, Clausen NT: Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues. Am J Hematol 2002, 70: 48-50.
36. Hartley BE, Searle AE, Breach NM, et al.: Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukaemia. J Laryngol Otol 1996, 110: 694-695.
37. Hsu CW, Krevsky B, Sigman LM, Thomas RM: Rapid progression of Barrett's esophagus to metastatic esophageal carcinoma in a patient with chronic lymphocytic leukemia. J Clin Gastroenterol 1998, 27: 261-264.
38. Nakamura N, Abe M: Richter syndrome in B-cell chronic lymphocytic leukemia. Pathol Int 2003, 53: 195-203.
39. Schmidt HH, Sill H, Eibl M, et al.: Hodgkin's disease developing after spontaneous remission of chronic lymphocytic leukemia. Ann Hematol 1995, 71: 247-252.
40. Gopal AK, Schuetze SM, Maloney DG, Weiden PL: Large cell non-Hodgkin's lymphoma and Hodgkin's disease arising synchronously in a patient with chronic lymphocytic leukemia: importance of immunochemistry. Blood 1999, 94: 2537.
41. Adiga GU, Abebe L, Wiernik PH: Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review. Am J Hematol 2003, 72: 267-273.
42. Naranjo TA, Matutes EI, Martinez JJ, et al.: Prolymphocytic leukaemia and Hodgkin's disease. Eur J Haematol 2002, 69: 182-184.
43. Robak T, Szmigelska-Kaplon A, Smolewski P, et al.: Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide. Leuk Lymphoma 2003, 44: 859-866.
44. Alliot C, Tabuteau S, Desablens B: Hodgkin's disease variant of Richter's syndrome: complete remission of both malignancies after 14 years. Hematology 2003, 8: 229-231.
45. Kyasa MJ Hazlett L, Parrish RS, et al.: Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death. Leuk Lymphoma 2004, 45: 507-513.
46. Smith KJ, Germain M, Skelton H: Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy. Dermatol Surg 2001, 27: 143-146.
47. Nouri K, O'Connell C, Rivas MP: Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma. Drugs Dermatol 2003, 2: 669-673.
48. Salim A, Leman JA, McColl JH, et al.: Randomized comparison of photodynamic therapy with topical fluorouracil in Bowen's disease. Br J Dermatol 2003, 148: 539-543.
49. Ziprin P, Smith S, Salerno G, Rosin RD: Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukaemia. Br J Dermatol 2000, 142: 525-528.
50. Vlad R, Woodlock TJ: Merkel cell carcinoma after chronic lymphocytic leukemia: case report and literature review. Am J Clin Oncol 2003, 26: 531-534.
51. Levi F, Randimbison L, Te VC, La Vecchia C: Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996, 74: 1847-1850.
52. Ramsay HM, Fryer A, Strange RC, Smith AG: Multiple basal cell carcinomas in a patient with acute myeloid leukaemia and chronic lymphocytic leukaemia. Clin Exp Dermatol 1999, 24: 281-282.
53. Weimar VM, Ceilley RI, Goeken JA: Aggressive biologic behavior of basal- and squamous-cell cancer in patients with chronic lymphocytic leukemia or chronic lymphocytic lymphoma. J Dermatol Surg Oncol 1979, 5: 609-614.
54. Mehrany K, Byrd DR, Roenigk RK, et al.: Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 2003, 29: 129-134.
55. McKenna DB, Doherty VR, McLaren KM, Hunter JA: Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br J Dermatol 2000, 143: 171-173.
56. Cahill RA, McGreal G, Neary P, Redmond HP: Synchronous high-risk melanoma and lymphoid neoplasia. Melanoma Res 2001, 11: 517-522.
57. Schmid-Wendtner MH, Lebeau A, Sander CA, et al.: Lymphadenopathy detected by ultrasound examination as first diagnostic hint of chronic lymphocytic leukaemia in a patient with melanoma. Eur Acad Dermatol Venereol 2002, 16: 491-493.
58. McKenna DB, Stockton D, Brewster DH, Doherty VR: Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 2003, 88: 74-78.
59. Konits PH, Aisner J, Whitacre M, Wiernik PH: Lung cancer as a complication of prolonged survival in patients with lymphoma. Med Pediatr Oncol 1982, 10: 331-338.
60. Travis LB, Gospodarowicz M, Curtis RE, et al.: Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002, 94: 182-192.
61. Gilbert ES, Stovall M, Gospodarowicz M, et al.: Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res 2003, 159: 161-173.
62. De Benedetti VM, Travis LB, Welsh JA, et al.: p53 mutations in lung cancer following radiation therapy for Hodgkin's disease. Cancer Epidemiol Biomarkers Prev 1996, 5: 93-98.
63. Parekh K, Rusch V, Kris M: The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia. Cancer 1999, 86: 1720-1723.
64. Potti A, Ganti AK, Koch M, et al.: Identification of HER2/neu overexpression and the clinical course of lung carcinoma in non-smokers with chronic lymphocytic leukemia. Lung Cancer 2001, 34: 227-232.
65. Davis JW, Weiss NS, Armstrong BK: Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1987, 78: 91-94.
66. Thomas R, Ribeiro I, Shepherd P, et al.: Spontaneous clinical regression in chronic lymphocytic leukaemia. Br J Haematol 2002, 116: 341-345.
67. Wiernik PH: Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr 1976, 44: 35-38.
68. Robak T, Blonski JZ, Gora-Tybor J, et al.: Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. Eur J Cancer 2004, 40: 383-389.
69. Mellemgaard A, Geisler CH, Storm HH: Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur J Haematol 1994, 53: 218-222.
70. Linet MS, Van Natta ML, Brookmeyer R, et al.: Familial cancer history and chronic lymphocytic leukemia: a case-control study. Am J Epidemiol 1989, 130: 655-664.
71. Shousha S, Costello C, Luqmani YA, Sinnett HD: CD5 positive breast carcinoma in a patient with untreated chronic lymphocytic leukaemia: molecular studies of chromosome 13q. J Clin Pathol 1998, 51: 862-864.
72. Rosen ST, Maciorowski Z, Wittlin F, et al.: Estrogen receptor analysis in chronic lymphocytic leukemia. Blood 1983, 62: 996-999.
73. Paietta E, Tudoriu CD, Goldstein M, et al.: Plasmacytoid blast crisis in B-cell chronic lymphocytic leukemia effect of estradiol on growth and differentiation in vitro. Leuk Res 1985, 9: 19-29.
74. Melo N, Hobday C, Dowsett M, et al.: Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods. Leuk Res 1990, 14: 949-952.
75. Hammarsund M, Corcoran MM, Wilson W, et al.: Characterization of a novel B-CLL candidate gene DLEU7, located in the 13q14 tumor suppressor locus. FEBS Lett 2004, 556: 75-80.
76. Sossey-Alaoui K, Kitamura E, Head K, Cowell JK: Characterization of FAM10A4, a member of the ST13 tumor suppressor gene family that maps to the 13q14.3 region associated with B-cell leukemia, multiple myeloma, and prostate cancer. Genomics 2002, 80: 5-7.
77. Ivanov DV, Tyazhelova TV, Lemonnier L, et al.: A new human gene KCNRG encoding potassium channel regulating protein is a cancer suppressor gene candidate located in 13q14.3. FEBS Lett 2003, 539: 156-160.
78. Terris MK, Hausdorff J, Freiha FS: Hematolymphoid malignancies diagnosed at the time of radical prostatectomy. J Urol 1997, 158: 1457-1459.
79. Weir EG, Epstein JI: Incidental small lymphocytic lymphoma/chronic lymphocytic leukemia in pelvic lymph nodes excised at radical prostatectomy. Arch Pathol Lab Med 2003, 127: 567-572.
80. Narasimhan P, Amaral L: Lymphopenic response of patients presenting with chronic lymphocytic leukemia associated with carcinoma of the prostate to diethylstilbestrol: correlation of response to the in vitro synthesis of RNA by patient lymphocytes and its relationship to transcortin. Am J Hematol 1980, 8: 369-375.
81. Teruya-Feldstein J, Greene J, Cohen L, et al.: Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer. Leuk Lymphoma 2002, 43: 1619-1626.
82. Kaplan MH, Susin M, Pahwa SG, et al.: Neoplastic complications of HTLV-III infection: lymphomas and solid tumors. Am J Med 1987, 82: 389-396.